Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Capital Expenditures: 2015-2024

Historic Capital Expenditures for Sunshine Biopharma (SBFM) over the last 9 years, with Dec 2024 value amounting to $1.7 million.

  • Sunshine Biopharma's Capital Expenditures fell 98.44% to $8,040 in Q3 2025 from the same period last year, while for Sep 2025 it was $278,130, marking a year-over-year decrease of 76.27%. This contributed to the annual value of $1.7 million for FY2024, which is 1914.63% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Capital Expenditures of $1.7 million as of FY2024, which was up 1,914.63% from $82,251 recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Capital Expenditures registered a high of $1.7 million during FY2024, and its lowest value of $1,191 during FY2020.
  • In the last 3 years, Sunshine Biopharma's Capital Expenditures had a median value of $193,982 in 2022 and averaged $644,429.
  • Its Capital Expenditures has fluctuated over the past 5 years, first tumbled by 57.60% in 2023, then skyrocketed by 1,914.63% in 2024.
  • Sunshine Biopharma's Capital Expenditures (Yearly) stood at $1,191 in 2020, then reached $193,982 in 2022, then crashed by 57.60% to $82,251 in 2023, then spiked by 1,914.63% to $1.7 million in 2024.